Overview

The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome

Status:
Completed

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

A retrospective real world analysis of bleeding events with ticagrelor compared to clopidogrel in ACS patients.

Details

Lead Sponsor:

Aintree University Hospitals NHS Foundation Trust
Liverpool University Hospitals NHS Foundation Trust

Collaborators:

Countess of Chester NHS Foundation Trust
Liverpool Heart and Chest Hospital NHS Foundation Trust
Royal Liverpool and Broadgreen University Hospitals NHS Trust
St Helens & Knowsley Teaching Hospitals NHS Trust

Treatments:

Clopidogrel
Ticagrelor
Ticlopidine